A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2
- PMID: 37938510
- DOI: 10.1007/s10528-023-10518-2
A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2
Abstract
COVID-19 (Coronavirus disease 2019) is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which can lead to pneumonia, cytokine storms, and lymphopenia. Patients with cancer are more susceptible to SARS-CoV-2 infection and severe COVID-19 due to immunosuppression. Recent studies have indicated that NRP1 (Neuropilin 1) may act as a novel mediator of SARS-CoV-2 entry into the host cell. As no systematic review has been performed investigating the characteristics of NRP1 in pan-carcinoma, we comprehensively analyzed NRP1 in patients with pan-cancer. Using a bioinformatics approach, we aimed to systematically examine NRP1 expression profiles in both pan-carcinoma and healthy tissues. We found that lung and genitourinary cancers have a relatively higher NRP-1 expression than other cancer patients, suggesting that these patients may be more susceptible to SARS-CoV-2. Our analysis further revealed that NRP1 expression was downregulated in Vero E6 cells, whole blood, lung organoids, testis tissue, and alveolospheres infected with SARS-CoV-2. Notably, NRP1 was associated with immune cell infiltration, immune checkpoint genes, and immune-related genes in most patients with cancer. These findings suggest that, in patients with specific types of cancer, especially lung and genitourinary, high expression of NRP1 contributes to greater susceptibility to SARS-CoV-2 infection and an increased risk of damage due to cytokine storms. Overall, NRP1 appears to play a critical role in regulating immunological properties and metabolism in many tumor types. Specific inhibitors of the NRP1 antigen (pegaptanib, EG00229, or MNRP1685A) combined with other anti-SARS-CoV-2 strategies may aid in treating patients with lung and genitourinary cancers following SARS-CoV-2 infection.
Keywords: COVID-19; Cancer; NRP1; SARS-CoV-2.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
In silico analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.Aging (Albany NY). 2021 Jun 24;13(12):15770-15784. doi: 10.18632/aging.203159. Epub 2021 Jun 24. Aging (Albany NY). 2021. PMID: 34168096 Free PMC article.
-
Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy.Front Genet. 2022 Oct 19;13:995736. doi: 10.3389/fgene.2022.995736. eCollection 2022. Front Genet. 2022. PMID: 36338984 Free PMC article.
-
Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2.Front Genet. 2022 Jun 17;13:883234. doi: 10.3389/fgene.2022.883234. eCollection 2022. Front Genet. 2022. PMID: 35783255 Free PMC article.
-
Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.Mol Med. 2021 Dec 27;27(1):162. doi: 10.1186/s10020-021-00423-y. Mol Med. 2021. PMID: 34961486 Free PMC article. Review.
-
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.Int J Mol Sci. 2021 Jun 1;22(11):5992. doi: 10.3390/ijms22115992. Int J Mol Sci. 2021. PMID: 34206057 Free PMC article. Review.
References
-
- Al Heialy S et al (2020) Regulation of angiotensin- converting enzyme 2 in obesity: implications for COVID-19. Front Physiol. https://doi.org/10.3389/fphys.2020.555039 - DOI - PubMed - PMC
-
- Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370:856–860. https://doi.org/10.1126/science.abd2985 - DOI - PubMed - PMC
-
- Chuckran CA, Liu C, Bruno TC, Workman CJ, Vignali DAA (2020) Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. J Immunother Cancer 8:e000967. https://doi.org/10.1136/jitc-2020-000967 - DOI - PubMed - PMC
-
- Daly JL et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370:861–865. https://doi.org/10.1126/science.abd3072 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous